The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, in partnership with the Authority of Social Contribution – Ma’an, the Abu Dhabi Government’s dedicated platform that connects the government, private sector, and wider community to address key social priorities, has awarded over AED 19 million in grants through the Healthcare Research and Innovation Fund.
These grants will support advancements in groundbreaking fields such as cell and gene therapies, precision medicine, and advanced cancer treatments, with the goal of transforming healthcare delivery and improving patient outcomes.
The accomplishment follows the recognition garnered during the inaugural Abu Dhabi Global Healthcare Week 2024, highlighting the close partnership between DoH, the Authority of Social Contribution – Ma’an and key community supporters with the mutual goal of enhancing the safety and well-being of Abu Dhabi’s community and beyond.
The Department awarded funding to 11 recipients, including academics, healthcare professionals, and innovators, to support their research and innovation projects under DoH’s Research and Innovation Centre. These projects are recognised for addressing critical healthcare challenges and advancing patient care.
The grant recipients are focused on advancing cancer research, leveraging technology and improving chronic disease management, by offering solutions such as virtual reality for breast cancer survivors, paediatric metabolic health, precision medicine, and treatments for inherited eye diseases. These diverse initiatives reinforce the transformative potential of medical research in solving pressing healthcare issues.
